Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study
Eun Ha Kang(Seoul National University Hospital), Seoyoung C. Kim(Brigham and Women's Hospital), Yeong Wook Song(Seoul National University of Science and Technology), Eun Bong Lee(Seoul National University Hospital), Anna Shin(Seoul National University Bundang Hospital), Hyon K. Choi(Boston University), Yun Jong Lee(Seoul National University)
Cited by 36
Related Papers
Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
|The American Journal of Medicine|2012|661
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574
Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility
|PLoS Genetics|2011|231
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
|Annals of the Rheumatic Diseases|2016|231
Antibiotic Use in Children – A Cross-National Analysis of 6 Countries
|The Journal of Pediatrics|2016|129